Epithelial ovarian cancer
Conditions
Interventions
Follow-up observation group:no
A drug maintenance treatment group:no
Two kinds of drugs maintenance treatment group:no
Sponsors
The Second Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ?Women over the age of 18 and having sex; ?Patients with epithelial ovarian cancer diagnosed by pathology; ?Can complete the established initial treatment plan (neoadjuvant chemotherapy + surgery + chemotherapy, surgery + chemotherapy, chemotherapy); ?Can or cannot complete BRCA gene and / or HRD detection; ?Complete remission, partial remission and disease stability were achieved at the completion of the initial treatment; ?Ensure that samples are taken as scheduled before the completion of the initial treatment, at the completion of the initial treatment and at the end of 1, 3, 6 and 12 months after the completion of the initial treatment.
Exclusion criteria
Exclusion criteria: ?A history of oral or intravenous infusion of antibiotics within 2 weeks before sampling; ?Patients with primary malignant tumors of other organs, benign diseases of digestive tract or rectovaginal fistula; ?Initial treatment combined with antineoplastic drugs except paclitaxel and carboplatin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 16s rRNA sequencing results;Evaluation of therapeutic response in solid tumors; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions; | — |
Countries
China
Contacts
Public ContactBuzhen Tan
The Second Affiliated Hospital of Nanchang University
Outcome results
None listed